FPR Specialty Pharmacy

Quick facts

Phase 3 pipeline

• Diclofenac Cream 8% · Pain Management, Rheumatology
  Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain at the site of topical application.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• FPR Specialty Pharmacy portfolio CI brief
• FPR Specialty Pharmacy pipeline updates RSS